Ryxel

healthcare News

Novo Nordisk surges 10% as FDA cracks down on copycat weight-loss drugs
Healthcare
1d ago

Novo Nordisk surges 10% as FDA cracks down on copycat weight-loss drugs

Regulatory action protects patent holders as compounded versions face restrictions after drug shortages declared resolved

Tenon Medical beats Q4 estimates as shares hit 52-week low
Healthcare
1d ago

Tenon Medical beats Q4 estimates as shares hit 52-week low

Preliminary results show 90% year-over-year growth but stock plunges amid broader market weakness

Immunovant beats earnings estimates as cash position nears $1bn
Healthcare
1d ago

Immunovant beats earnings estimates as cash position nears $1bn

Biotech advances IMVT-1402 trials while cutting costs by 22%

Roivant climbs 4% on brepocitinib data despite Q3 earnings miss
Healthcare
1d ago

Roivant climbs 4% on brepocitinib data despite Q3 earnings miss

Phase 2 cutaneous sarcoidosis results show 21.6-point improvement versus placebo as NDA filed for dermatomyositis

Biogen tops earnings estimates on LEQEMBI growth, cost cuts
Healthcare
1d ago

Biogen tops earnings estimates on LEQEMBI growth, cost cuts

Biotech company's 2026 profit forecast exceeds analyst expectations amid Alzheimer's drug momentum

Biogen exceeds estimates as Alzheimer's drug growth offsets MS decline
Healthcare
1d ago

Biogen exceeds estimates as Alzheimer's drug growth offsets MS decline

FY26 guidance of $15.25-$16.25 beats analyst consensus on cost-cutting and LEQEMBI momentum

Ocular Therapeutix cash runway fuels $24.25 target amid AXPAXLI trial
Healthcare
2d ago

Ocular Therapeutix cash runway fuels $24.25 target amid AXPAXLI trial

Revenue declines to $13.3M but $737.1M balance supports operations through 2028

Embecta beats earnings estimates on strong international growth
Healthcare
2d ago

Embecta beats earnings estimates on strong international growth

Diabetes care company maintains FY26 guidance despite 7.6% U.S. revenue decline